NCT02420808

Brief Summary

A nationwide registry of patients with acute coronary disease to evaluate epidemiological patient characteristics, medical management, implementation of invasive strategy, patient outcome and impact on quality of life in Greece.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
800

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2012

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2013

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2014

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

April 15, 2015

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 20, 2015

Completed
Last Updated

March 3, 2017

Status Verified

March 1, 2017

Enrollment Period

1.3 years

First QC Date

April 15, 2015

Last Update Submit

March 1, 2017

Conditions

Keywords

CADSTEMInon STEMIUnstable anginaGreece

Outcome Measures

Primary Outcomes (1)

  • Evaluation of patients with Acute Coronary Syndromes.

    Assessment of the epidemiological characteristics of patients who were hospitalized with a diagnosis of ACS. Evaluation of the therapeutic strategy and its outcome.

    6 months

Secondary Outcomes (6)

  • Estimation of the percentage of patients.

    Baseline

  • Description of the methods of patients' evacuation.

    Baseline

  • Estimation of the interval until the arrival in the hospital.

    Baseline

  • Evaluation of the blood test analysis during hospitalization.

    Baseline

  • Description of the administered medication.

    Baseline - 6 months

  • +1 more secondary outcomes

Eligibility Criteria

Age25 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with ACS

You may qualify if:

  • Informed Consent
  • \> 25 years
  • Admission in hospital within 24 hours from beginning of symptoms of transfer from antother hospital within 24 hours from beginning of symptoms.
  • Acute Coronary Syndrom

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

General Hospital of Chalkida

Chalcis, Greece

Location

MeSH Terms

Conditions

Coronary Artery DiseaseST Elevation Myocardial InfarctionNon-ST Elevated Myocardial InfarctionAngina, Unstable

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular DiseasesMyocardial InfarctionInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosisAngina PectorisChest PainPainNeurologic ManifestationsSigns and Symptoms

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 15, 2015

First Posted

April 20, 2015

Study Start

March 1, 2012

Primary Completion

June 1, 2013

Study Completion

January 1, 2014

Last Updated

March 3, 2017

Record last verified: 2017-03

Locations